Age-specific eNOS polymorphisms in moyamoya disease

Young Seok Park, Kyung Tae Min, Tae Gon Kim, Yun Ho Lee, Hee-Jin Cheong, In Sun Yeom, Joong Uhn Choi, Dong Seok Kim, Nam Keun Kim

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

Objective: We conducted a case-control study to investigate whether polymorphisms in eNOS are related to the age-specific onset of moyamoya disease. Materials and methods: Ninety-three Korean patients [mean age, 23.0±16.1 years; 59 female (63.4%) and 34 male (36.6%)] with moyamoya disease were consecutively recruited for this study. Three hundred twenty-eight healthy subjects [mean age, 27.7±16.2 years; 217 female (66.2%), 111 male (33.8%)] were consecutively included in the control group. The subjects were divided into pediatric (<20 years) and adult (≥20 years) groups. We further divided the moyamoya group into ischemic and hemorrhagic groups based on clinical and MRI findings. The frequencies and distributions of four eNOS polymorphisms (eNOS -922A>G, -786T>C, 4a4b, and 894G>T) were assessed in pediatric and adult patients with moyamoya disease and compared to the frequencies and distribution in the control group. Results: No differences in eNOS polymorphisms were observed between control and moyamoya disease group. However, we found that the 4a4b sequences was less frequent in the adult group (p=0.029). Compared to the control group, there were differences in the haplotype distribution of the study group, specifically the A-4b-G haplotype, which was seen more frequently in the adult patient group. Conclusion: Our results suggest that pediatric and adult-onset moyamoya disease have different genetic backgrounds. These genetic differences can affect age-specific clinical characteristics, such as cerebral ischemia and hemorrhage.

Original languageEnglish
Pages (from-to)1919-1926
Number of pages8
JournalChild's Nervous System
Volume27
Issue number11
DOIs
Publication statusPublished - 2011 Nov 1
Externally publishedYes

Fingerprint

Moyamoya Disease
Pediatrics
Control Groups
Haplotypes
Cerebral Hemorrhage
Brain Ischemia
Age of Onset
Case-Control Studies
Healthy Volunteers

Keywords

  • eNOS
  • Moyamoya disease
  • Nitric oxide
  • Polymorphism

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Clinical Neurology

Cite this

Park, Y. S., Min, K. T., Kim, T. G., Lee, Y. H., Cheong, H-J., Yeom, I. S., ... Kim, N. K. (2011). Age-specific eNOS polymorphisms in moyamoya disease. Child's Nervous System, 27(11), 1919-1926. https://doi.org/10.1007/s00381-011-1504-z

Age-specific eNOS polymorphisms in moyamoya disease. / Park, Young Seok; Min, Kyung Tae; Kim, Tae Gon; Lee, Yun Ho; Cheong, Hee-Jin; Yeom, In Sun; Choi, Joong Uhn; Kim, Dong Seok; Kim, Nam Keun.

In: Child's Nervous System, Vol. 27, No. 11, 01.11.2011, p. 1919-1926.

Research output: Contribution to journalArticle

Park, YS, Min, KT, Kim, TG, Lee, YH, Cheong, H-J, Yeom, IS, Choi, JU, Kim, DS & Kim, NK 2011, 'Age-specific eNOS polymorphisms in moyamoya disease', Child's Nervous System, vol. 27, no. 11, pp. 1919-1926. https://doi.org/10.1007/s00381-011-1504-z
Park, Young Seok ; Min, Kyung Tae ; Kim, Tae Gon ; Lee, Yun Ho ; Cheong, Hee-Jin ; Yeom, In Sun ; Choi, Joong Uhn ; Kim, Dong Seok ; Kim, Nam Keun. / Age-specific eNOS polymorphisms in moyamoya disease. In: Child's Nervous System. 2011 ; Vol. 27, No. 11. pp. 1919-1926.
@article{afd4af78ead9425593462e73a5e053d5,
title = "Age-specific eNOS polymorphisms in moyamoya disease",
abstract = "Objective: We conducted a case-control study to investigate whether polymorphisms in eNOS are related to the age-specific onset of moyamoya disease. Materials and methods: Ninety-three Korean patients [mean age, 23.0±16.1 years; 59 female (63.4{\%}) and 34 male (36.6{\%})] with moyamoya disease were consecutively recruited for this study. Three hundred twenty-eight healthy subjects [mean age, 27.7±16.2 years; 217 female (66.2{\%}), 111 male (33.8{\%})] were consecutively included in the control group. The subjects were divided into pediatric (<20 years) and adult (≥20 years) groups. We further divided the moyamoya group into ischemic and hemorrhagic groups based on clinical and MRI findings. The frequencies and distributions of four eNOS polymorphisms (eNOS -922A>G, -786T>C, 4a4b, and 894G>T) were assessed in pediatric and adult patients with moyamoya disease and compared to the frequencies and distribution in the control group. Results: No differences in eNOS polymorphisms were observed between control and moyamoya disease group. However, we found that the 4a4b sequences was less frequent in the adult group (p=0.029). Compared to the control group, there were differences in the haplotype distribution of the study group, specifically the A-4b-G haplotype, which was seen more frequently in the adult patient group. Conclusion: Our results suggest that pediatric and adult-onset moyamoya disease have different genetic backgrounds. These genetic differences can affect age-specific clinical characteristics, such as cerebral ischemia and hemorrhage.",
keywords = "eNOS, Moyamoya disease, Nitric oxide, Polymorphism",
author = "Park, {Young Seok} and Min, {Kyung Tae} and Kim, {Tae Gon} and Lee, {Yun Ho} and Hee-Jin Cheong and Yeom, {In Sun} and Choi, {Joong Uhn} and Kim, {Dong Seok} and Kim, {Nam Keun}",
year = "2011",
month = "11",
day = "1",
doi = "10.1007/s00381-011-1504-z",
language = "English",
volume = "27",
pages = "1919--1926",
journal = "Child's Nervous System",
issn = "0256-7040",
publisher = "Springer Verlag",
number = "11",

}

TY - JOUR

T1 - Age-specific eNOS polymorphisms in moyamoya disease

AU - Park, Young Seok

AU - Min, Kyung Tae

AU - Kim, Tae Gon

AU - Lee, Yun Ho

AU - Cheong, Hee-Jin

AU - Yeom, In Sun

AU - Choi, Joong Uhn

AU - Kim, Dong Seok

AU - Kim, Nam Keun

PY - 2011/11/1

Y1 - 2011/11/1

N2 - Objective: We conducted a case-control study to investigate whether polymorphisms in eNOS are related to the age-specific onset of moyamoya disease. Materials and methods: Ninety-three Korean patients [mean age, 23.0±16.1 years; 59 female (63.4%) and 34 male (36.6%)] with moyamoya disease were consecutively recruited for this study. Three hundred twenty-eight healthy subjects [mean age, 27.7±16.2 years; 217 female (66.2%), 111 male (33.8%)] were consecutively included in the control group. The subjects were divided into pediatric (<20 years) and adult (≥20 years) groups. We further divided the moyamoya group into ischemic and hemorrhagic groups based on clinical and MRI findings. The frequencies and distributions of four eNOS polymorphisms (eNOS -922A>G, -786T>C, 4a4b, and 894G>T) were assessed in pediatric and adult patients with moyamoya disease and compared to the frequencies and distribution in the control group. Results: No differences in eNOS polymorphisms were observed between control and moyamoya disease group. However, we found that the 4a4b sequences was less frequent in the adult group (p=0.029). Compared to the control group, there were differences in the haplotype distribution of the study group, specifically the A-4b-G haplotype, which was seen more frequently in the adult patient group. Conclusion: Our results suggest that pediatric and adult-onset moyamoya disease have different genetic backgrounds. These genetic differences can affect age-specific clinical characteristics, such as cerebral ischemia and hemorrhage.

AB - Objective: We conducted a case-control study to investigate whether polymorphisms in eNOS are related to the age-specific onset of moyamoya disease. Materials and methods: Ninety-three Korean patients [mean age, 23.0±16.1 years; 59 female (63.4%) and 34 male (36.6%)] with moyamoya disease were consecutively recruited for this study. Three hundred twenty-eight healthy subjects [mean age, 27.7±16.2 years; 217 female (66.2%), 111 male (33.8%)] were consecutively included in the control group. The subjects were divided into pediatric (<20 years) and adult (≥20 years) groups. We further divided the moyamoya group into ischemic and hemorrhagic groups based on clinical and MRI findings. The frequencies and distributions of four eNOS polymorphisms (eNOS -922A>G, -786T>C, 4a4b, and 894G>T) were assessed in pediatric and adult patients with moyamoya disease and compared to the frequencies and distribution in the control group. Results: No differences in eNOS polymorphisms were observed between control and moyamoya disease group. However, we found that the 4a4b sequences was less frequent in the adult group (p=0.029). Compared to the control group, there were differences in the haplotype distribution of the study group, specifically the A-4b-G haplotype, which was seen more frequently in the adult patient group. Conclusion: Our results suggest that pediatric and adult-onset moyamoya disease have different genetic backgrounds. These genetic differences can affect age-specific clinical characteristics, such as cerebral ischemia and hemorrhage.

KW - eNOS

KW - Moyamoya disease

KW - Nitric oxide

KW - Polymorphism

UR - http://www.scopus.com/inward/record.url?scp=80054736127&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=80054736127&partnerID=8YFLogxK

U2 - 10.1007/s00381-011-1504-z

DO - 10.1007/s00381-011-1504-z

M3 - Article

C2 - 21691823

AN - SCOPUS:80054736127

VL - 27

SP - 1919

EP - 1926

JO - Child's Nervous System

JF - Child's Nervous System

SN - 0256-7040

IS - 11

ER -